BDSI BioDelivery Sciences International, Inc. Stock Quote

BDSI [NASD]

BioDelivery Sciences International, Inc.

Index	-	P/E	14.67	EPS (ttm)	0.24	Insider Own	0.40%	Shs Outstand	101.19M	Perf Week	-5.08%
Market Cap	368.10M	Forward P/E	6.66	EPS next Y	0.53	Insider Trans	-12.98%	Shs Float	98.56M	Perf Month	-12.99%
Income	25.70M	PEG	0.59	EPS next Q	0.07	Inst Own	69.80%	Short Float	3.65%	Perf Quarter	-27.10%
Sales	156.50M	P/S	2.35	EPS this Y	233.10%	Inst Trans	-1.02%	Short Ratio	2.82	Perf Half Y	-7.31%
Book/sh	1.07	P/B	3.32	EPS next Y	83.79%	ROA	11.60%	Target Price	-	Perf Year	-12.13%
Cash/sh	1.08	P/C	3.30	EPS next 5Y	25.00%	ROE	28.10%	52W Range	3.04 - 5.45	Perf YTD	-15.48%
Dividend	-	P/FCF	-	EPS past 5Y	18.50%	ROI	17.50%	52W High	-34.86%	Beta	0.75
Dividend %	-	Quick Ratio	3.10	Sales past 5Y	26.50%	Gross Margin	84.20%	52W Low	16.78%	ATR	0.19
Employees	176	Current Ratio	3.40	Sales Q/Q	33.50%	Oper. Margin	21.10%	RSI (14)	39.89	Volatility	3.89% 4.99%
Optionable	Yes	Debt/Eq	0.73	EPS Q/Q	-	Profit Margin	16.40%	Rel Volume	1.05	Prev Close	3.65
Shortable	Yes	LT Debt/Eq	0.73	Earnings	Mar 10 BMO	Payout	0.00%	Avg Volume	1.27M	Price	3.55
Recom	1.90	SMA20	-5.36%	SMA50	-11.36%	SMA200	-12.91%	Volume	1,334,062	Change	-2.74%

Apr-22-20

Initiated

Northland Capital

Outperform

Jan-09-20

Initiated

Piper Sandler

Overweight

Mar-20-19

Initiated

SunTrust

Buy

Jan-31-19

Resumed

Janney

Buy

Jan-26-18

Initiated

Seaport Global Securities

Buy

Aug-14-17

Resumed

Cantor Fitzgerald

Overweight

$4.50

Aug-10-17

Reiterated

H.C. Wainwright

Buy

$4 → $5

May-26-17

Initiated

H.C. Wainwright

Buy

May-17-17

Upgrade

Cantor Fitzgerald

Neutral → Overweight

May-12-16

Reiterated

Piper Jaffray

Overweight

$6 → $4

May-11-16

Downgrade

Cantor Fitzgerald

Buy → Hold

May-04-16

Reiterated

FBR Capital

Outperform

$12 → $9

Mar-14-16

Reiterated

Laidlaw

Buy

$17 → $11

Mar-11-16

Reiterated

FBR Capital

Outperform

$13 → $12

Feb-08-16

Initiated

Piper Jaffray

Overweight

Nov-10-15

Reiterated

FBR Capital

Mkt Perform

$17 → $14

Nov-04-15

Initiated

Cantor Fitzgerald

Buy

May-12-15

Reiterated

Cantor Fitzgerald

Buy

$17 → $12

May-11-15

Reiterated

ROTH Capital

Buy

$16 → $14

Apr-22-15

Resumed

Piper Jaffray

Overweight

Apr-09-21 11:30AM	BioDelivery (BDSI) Down 12.8% Since Last Earnings Report: Can It Rebound? Zacks
Mar-30-21 07:22AM	Moving Average Crossover Alert: BioDelivery Sciences (BDSI) Zacks
Mar-22-21 01:33AM	What Kind Of Shareholders Own BioDelivery Sciences International, Inc. (NASDAQ:BDSI)? Simply Wall St.
Mar-18-21 06:02PM	Top Biotech Stocks for Q2 2021 Investopedia
Mar-10-21 03:30PM	Biodelivery Sciences International Inc (BDSI) Q4 2020 Earnings Call Transcript Motley Fool
10:12AM	BioDelivery (BDSI) Beats Q4 Earnings Estimates, Stock Up Zacks
08:31AM	Recap: BioDelivery Sciences Q4 Earnings Benzinga
08:00AM	BioDelivery Sciences Reports Strong Q4 and Record Full-Year 2020 Results GlobeNewswire
05:30AM	BioDelivery Sciences International, Inc. to Host Earnings Call ACCESSWIRE
Mar-03-21 12:30PM	Earnings Preview: BioDelivery Sciences International (BDSI) Q4 Earnings Expected to Decline Zacks
Feb-17-21 08:00AM	BioDelivery Sciences to Report Fourth Quarter and Full Year 2020 Financial Results on March 10, 2021 GlobeNewswire +6.29%
Feb-11-21 08:00AM	BioDelivery Sciences CFO Terry Coelho Promoted to Executive Vice President GlobeNewswire
Feb-08-21 10:11AM	10 Best Small-Cap Biotech Stocks Under $10 in 2021 Insider Monkey
Feb-05-21 01:07AM	Introducing BioDelivery Sciences International (NASDAQ:BDSI), A Stock That Climbed 79% In The Last Three Years Simply Wall St.
Jan-15-21 09:00AM	BioDelivery Sciences to Present Three Scientific Posters Comparing BELBUCA® to Oxycodone at the 2021 North American Neuromodulation Society (NANS) Meeting GlobeNewswire
Dec-21-20 11:54PM	Are Robust Financials Driving The Recent Rally In BioDelivery Sciences International, Inc.'s (NASDAQ:BDSI) Stock? Simply Wall St.
Dec-19-20 06:11PM	Is BDSI A Good Stock To Buy? Insider Monkey
Dec-05-20 11:31AM	BioDelivery (BDSI) Up 9.5% Since Last Earnings Report: Can It Continue? Zacks
Nov-20-20 08:30AM	BioDelivery Sciences to Participate in the Piper Sandler 32nd Annual Healthcare Conference GlobeNewswire
Nov-17-20 09:40AM	Is a BioDelivery Sciences (BDSI) Good Value Investor Stock? Zacks
Nov-11-20 08:30AM	BioDelivery Sciences to Present Virtually and Host 1x1 Investor Meetings at the Annual Southwest IDEAS Investor Conference on November 18 GlobeNewswire
Nov-07-20 08:02AM	BioDelivery Sciences International, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year Simply Wall St.
Nov-06-20 06:00AM	Is BioDelivery Sciences International (NASDAQ:BDSI) Using Too Much Debt? Simply Wall St. -8.70%
Nov-05-20 07:00PM	Biodelivery Sciences International Inc (BDSI) Q3 2020 Earnings Call Transcript Motley Fool +6.36%
08:00AM	BioDelivery Sciences Reports Strong Q3 2020 Results GlobeNewswire
Nov-04-20 05:31PM	BioDelivery Sciences Announces $25 Million Share Repurchase Program GlobeNewswire
05:11PM	BioDelivery Sciences Announces Appointment of Jeff Bailey as Permanent CEO GlobeNewswire
Oct-23-20 08:00AM	BioDelivery Sciences to Report Third Quarter 2020 Financial Results on November 5, 2020 GlobeNewswire
Sep-28-20 10:41AM	BioDelivery Sciences Intl (BDSI): Hedge Funds Taking Some Chips Off The Table Insider Monkey
Sep-24-20 10:46AM	3 Strong Buy Healthcare Stocks Under $5 With Triple-Digit Growth Prospects TipRanks
08:31AM	Is BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Popular Amongst Institutions? Simply Wall St.
Sep-14-20 12:06PM	20 Most Drug Infested Cities in the U.S. Insider Monkey
Sep-11-20 08:00AM	BioDelivery Sciences Announces Five Scientific Poster Presentations at PAINWeek® 2020 National Conference on Pain Management GlobeNewswire
Sep-04-20 11:31AM	BioDelivery (BDSI) Down 15.5% Since Last Earnings Report: Can It Rebound? Zacks
Sep-03-20 08:00AM	BioDelivery Sciences to Present at Two Upcoming Investor Conferences GlobeNewswire
Aug-10-20 09:08AM	BioDelivery Sciences International (NASDAQ:BDSI) Shareholders Have Enjoyed A 53% Share Price Gain Simply Wall St.
Aug-06-20 10:05AM	BioDelivery (BDSI) Q2 Earnings Miss, Revenues Beat, Stock Up Zacks
Aug-05-20 09:05AM	BioDelivery Sciences International (BDSI) Q2 Earnings Lag Estimates Zacks
07:45AM	BioDelivery Sciences Reports Strong Q2 2020 Results GlobeNewswire
Jul-29-20 12:33PM	Earnings Preview: BioDelivery Sciences International (BDSI) Q2 Earnings Expected to Decline Zacks
Jul-27-20 04:01PM	BioDelivery Sciences to Report Second Quarter 2020 Financial Results on August 5, 2020 GlobeNewswire
Jul-12-20 07:39PM	Did Hedge Funds Make The Right Call On BioDelivery Sciences International, Inc. (BDSI) ? Insider Monkey
Jun-10-20 05:44PM	Hedge Funds Have Never Been This Bullish On BioDelivery Sciences International, Inc. (BDSI) Insider Monkey
Jun-09-20 11:38PM	Edited Transcript of BDSI earnings conference call or presentation 7-May-20 8:30pm GMT Thomson Reuters StreetEvents -8.09%
Jun-06-20 11:31AM	Why Is BioDelivery (BDSI) Down 0.4% Since Last Earnings Report? Zacks
May-29-20 12:17PM	BioDelivery Sciences to Present at Two Upcoming Investor Conferences GlobeNewswire
May-26-20 10:43AM	Baker Brothers Snap Up These 3 Small-Cap Biotech Stocks TipRanks
May-11-20 08:30AM	BioDelivery Sciences Appoints Jeff Bailey Interim CEO GlobeNewswire -6.50%
May-09-20 05:01PM	Biodelivery Sciences International Inc (BDSI) Q1 2020 Earnings Call Transcript Motley Fool
May-08-20 10:52AM	BioDelivery (BDSI) Beats on Q1 Earnings, Withdraws Guidance Zacks +5.18%
May-07-20 06:35PM	BioDelivery Sciences International (BDSI) Beats Q1 Earnings and Revenue Estimates Zacks
04:01PM	BioDelivery Sciences Reports Strong Q1 2020 Results GlobeNewswire
Apr-30-20 12:34PM	BioDelivery Sciences International (BDSI) Earnings Expected to Grow: Should You Buy? Zacks
Apr-28-20 08:00AM	BioDelivery Sciences to Report First Quarter 2020 Financial Results on May 7, 2020 GlobeNewswire
Apr-27-20 12:31PM	BioDelivery Sciences International (BDSI) Earnings Expected to Grow: Should You Buy? Zacks +6.19%
Mar-24-20 10:02PM	Edited Transcript of BDSI earnings conference call or presentation 12-Mar-20 8:30pm GMT Thomson Reuters StreetEvents +9.32%
Mar-14-20 08:51AM	Does BioDelivery Sciences International (NASDAQ:BDSI) Have A Healthy Balance Sheet? Simply Wall St.
Mar-13-20 09:29AM	BioDelivery (BDSI) Q4 Earnings and Revenues Beat Estimates Zacks +9.84%
Mar-12-20 08:55PM	BioDelivery Sciences International (BDSI) Tops Q4 Earnings and Revenue Estimates Zacks -5.05%
04:01PM	BioDelivery Sciences Reports Strong Fourth Quarter and Full-Year 2019 Results GlobeNewswire
02:30PM	BioDelivery Sciences International, Inc. to Host Earnings Call ACCESSWIRE
Mar-09-20 08:00AM	BioDelivery Sciences Appoints Jeffrey A. Bailey to its Board of Directors GlobeNewswire -6.05%
Mar-05-20 12:30PM	BioDelivery Sciences International (BDSI) Earnings Expected to Grow: Should You Buy? Zacks
Feb-27-20 05:15PM	BioDelivery Sciences Announces Phase I Clinical Trial Results at the American Academy of Pain Medicines 36th Annual Meeting GlobeNewswire
Feb-24-20 02:59PM	Advance Auto Parts, Cree among Triangle companies hit as stocks tumble with rising concern over coronavirus American City Business Journals -5.58%
Feb-20-20 08:00AM	BioDelivery Sciences to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020 GlobeNewswire
Feb-06-20 10:44AM	Emmaus (EMMA) to Report Q4 Earnings: What's in the Cards? Zacks
Jan-30-20 10:15AM	Alexion (ALXN) Q4 Earnings Beat Estimates, Revenues Up Y/Y Zacks
Jan-29-20 10:06AM	Gilead's Mantle Cell Lymphoma Drug MAA Gets EMA Validation Zacks
Jan-27-20 05:20PM	Here's Why You Should Add BioDelivery Stock to Your Portfolio Zacks
10:25AM	Will Soliris, Ultomiris Drive Alexion's (ALXN) Q4 Earnings? Zacks
Jan-13-20 08:30AM	BDSI Expects Fourth Quarter and 2019 Total Net Sales at the High End of Guidance: Reports Significantly Expanded Insurance Access for Symproic GlobeNewswire
Jan-08-20 12:00PM	What Makes BioDelivery (BDSI) a New Buy Stock Zacks
Jan-06-20 08:30AM	BioDelivery Sciences Appoints Kevin Ostrander as Senior Vice President of Business Development GlobeNewswire
Dec-30-19 09:44AM	Flexion's (FLXN) Stock Up on FDA Approval for Zilretta sNDA Zacks
Dec-27-19 07:53PM	Argo Group, Tivity Health, Horizon Global, and Other 13D Filings Barrons.com -6.52%
Dec-25-19 12:00PM	Are You Looking for a Top Momentum Pick? Why BioDelivery Sciences International (BDSI) is a Great Choice Zacks
Dec-19-19 08:30AM	BioDelivery Sciences Added to NASDAQ Biotechnology Index GlobeNewswire
Dec-12-19 11:30AM	BioDelivery (BDSI) Up 6% Since Last Earnings Report: Can It Continue? Zacks
Dec-10-19 10:48AM	Did Hedge Funds Drop The Ball On BioDelivery Sciences International, Inc. (BDSI) ? Insider Monkey
Dec-06-19 12:00PM	What Makes BioDelivery Sciences International (BDSI) a Strong Momentum Stock: Buy Now? Zacks
Dec-05-19 09:07AM	Zealand Initiates Second Late-Stage CHI Study on Dasiglucagon Zacks
Dec-04-19 11:05AM	Edited Transcript of BDSI earnings conference call or presentation 12-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
10:06AM	Zacks.com featured highlights include: Sciences International, Air Industries, Hallmark Financial Services and Vector Zacks
Dec-03-19 09:16AM	Amarin's Vascepa MAA for Heart Risk Indication Accepted in EU Zacks
08:57AM	5 Affordable Breakout Stocks for Stunning Returns Zacks
Nov-29-19 09:13AM	BioDelivery's Belbuca Sales & Symproic Addition Encouraging Zacks
Nov-27-19 08:30AM	BioDelivery Sciences to Present at the Piper Jaffray 31st Annual Healthcare Conference GlobeNewswire +5.93%
Nov-25-19 08:30AM	BioDelivery Sciences Appoints Dr. Vanila Singh, Former Chief Medical Officer of Health and Human Services, to its Board of Directors GlobeNewswire
Nov-22-19 09:48AM	The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical Zacks
Nov-20-19 10:00AM	What Makes BioDelivery Sciences International (BDSI) a Strong Momentum Stock: Buy Now? Zacks
Nov-19-19 09:26AM	Protalix Finalizes Accelerated Approval Pathway for PRX-102 Zacks
Nov-14-19 10:20AM	BioDelivery (BDSI) Stock Up on Q3 Earnings Beat & Raised View Zacks
Nov-13-19 08:00AM	IVERIC bio (ISEE) Q3 Loss Narrows Y/Y, Zimura Advancing Well Zacks
07:49AM	5 Breakout Stocks for Explosive Returns Zacks
Nov-12-19 05:25PM	BioDelivery Sciences International (BDSI) Beats Q3 Earnings and Revenue Estimates Zacks
04:01PM	BioDelivery Sciences Reports Strong Third Quarter Results, Raises Full Year 2019 and Provides 2020 Net Sales Expectations GlobeNewswire
Nov-07-19 08:00AM	BioDelivery Sciences to Present at the 10th Annual Jefferies Global Healthcare Conference in London GlobeNewswire
Nov-06-19 05:38AM	Introducing BioDelivery Sciences International (NASDAQ:BDSI), The Stock That Zoomed 197% In The Last Three Years Simply Wall St.
Nov-05-19 10:31AM	BioDelivery Sciences International (BDSI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. The company also offers Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Plesha Scott M.	See Remarks	Mar 12	Option Exercise	0.00	20,834	0	299,874	Mar 16 04:57 PM
Bailey Jeffrey Allen	Chief Executive Officer	Mar 09	Option Exercise	0.00	5,333	0	40,900	Mar 11 04:14 PM
Vollins James	See Remarks	Feb 08	Sale	4.16	3,833	15,945	0	Feb 08 05:46 PM
Vollins James	See Remarks	Feb 04	Sale	3.97	8,303	32,963	3,833	Feb 08 05:46 PM
Vollins James	See Remarks	Feb 01	Option Exercise	0.00	3,833	0	12,136	Feb 02 05:59 PM
Smith Thomas B	Chief Medical Officer	Feb 01	Option Exercise	0.00	7,667	0	19,954	Feb 02 05:55 PM
Plesha Scott M.	See Remarks	Feb 01	Option Exercise	0.00	13,333	0	258,206	Feb 02 06:17 PM
Coelho Mary Theresa	See Remarks	Feb 01	Sale	3.87	3,460	13,390	30,619	Feb 02 07:12 PM
Coelho Mary Theresa	See Remarks	Jan 29	Option Exercise	0.00	10,190	0	34,079	Feb 02 07:12 PM
Plesha Scott M.	See Remarks	Jan 29	Option Exercise	0.00	10,870	0	244,873	Feb 02 06:17 PM
Smith Thomas B	Chief Medical Officer	Jan 29	Option Exercise	0.00	7,548	0	12,287	Feb 02 05:55 PM
Vollins James	See Remarks	Jan 29	Option Exercise	0.00	8,303	0	8,303	Feb 02 05:59 PM
Coelho Mary Theresa	See Remarks	Jan 19	Sale	4.32	6,462	27,916	23,889	Jan 20 04:30 PM
Coelho Mary Theresa	See Remarks	Jan 15	Option Exercise	0.00	18,333	0	30,351	Jan 20 04:30 PM
Vollins James	See Remarks	Dec 16	Option Exercise	3.46	9,505	32,887	9,505	Dec 16 04:39 PM
Vollins James	See Remarks	Dec 16	Sale	4.48	9,505	42,582	0	Dec 16 04:39 PM
Bailey Jeffrey Allen	Chief Executive Officer	Dec 15	Sale	4.35	10,000	43,500	35,567	Dec 16 04:41 PM
Vollins James	See Remarks	Dec 14	Option Exercise	3.46	20,320	70,307	20,320	Dec 16 04:39 PM
Vollins James	See Remarks	Dec 14	Sale	4.46	20,320	90,627	0	Dec 16 04:39 PM
Singh Vanila	Director	Nov 23	Option Exercise	0.00	5,333	0	12,084	Nov 27 04:16 PM
Bailey Jeffrey Allen	Chief Executive Officer	Nov 04	Option Exercise	0.00	40,000	0	45,567	Nov 06 05:21 PM
Davis Todd C	Director	Aug 18	Sale	4.99	50,000	249,500	217,914	Aug 20 04:16 PM
Watson W. Mark	Director	Aug 17	Sale	5.18	13,000	67,340	52,979	Aug 19 04:30 PM
Sirgo Mark A	Director	Aug 14	Sale	4.90	115,000	563,500	1,091,095	Aug 17 06:58 PM
Sirgo Mark A	Director	Aug 13	Sale	4.53	85,000	385,050	1,206,095	Aug 17 06:58 PM
KOTLER KEVIN	Director	Aug 07	Option Exercise	0.98	45,000	43,950	4,355,689	Aug 11 05:16 PM
Greenleaf Peter	Director	Aug 07	Option Exercise	0.00	35,000	0	59,788	Aug 11 05:03 PM
Sirgo Mark A	Director	Aug 07	Option Exercise	0.00	4,000	0	1,291,095	Aug 11 04:55 PM
Singh Vanila	Director	Aug 07	Option Exercise	0.00	6,751	0	6,751	Aug 11 04:54 PM
Bailey Jeffrey Allen	Chief Executive Officer	Aug 07	Option Exercise	0.00	5,567	0	5,567	Aug 11 04:53 PM
Watson W. Mark	Director	Aug 07	Option Exercise	0.00	30,000	0	65,979	Aug 11 04:51 PM
Davis Todd C	Director	Aug 07	Option Exercise	0.00	30,000	0	267,914	Aug 11 04:50 PM
Vollins James	See Remarks	May 21	Option Exercise	3.90	21,666	84,497	21,666	May 22 04:04 PM
Vollins James	See Remarks	May 21	Sale	4.60	21,666	99,664	0	May 22 04:04 PM
Plesha Scott M.	See Remarks	May 18	Sale	4.52	15,000	67,800	234,003	May 20 04:38 PM
ODONNELL FRANCIS E JR	Director	May 11	Option Exercise	0.00	22,500	0	628,038	May 14 04:07 PM
Sirgo Mark A	Director	May 11	Option Exercise	0.00	22,500	0	1,287,095	May 12 06:48 PM
Sirgo Mark A	Director	May 08	Sale	5.07	100,000	507,000	1,264,595	May 12 06:48 PM
ODONNELL FRANCIS E JR	Director	May 06	Sale	4.53	11,250	50,962	605,538	May 08 04:06 PM
Cukier Herm	Chief Executive Officer	May 04	Option Exercise	0.00	66,666	0	102,447	May 05 04:05 PM
ODONNELL FRANCIS E JR	Director	May 04	Sale	4.45	16,000	71,200	616,788	May 05 04:06 PM
Sirgo Mark A	Director	Apr 27	Sale	4.58	100,000	458,000	1,364,595	Apr 29 04:10 PM
ODONNELL FRANCIS E JR	Director	Apr 20	Sale	4.22	20,000	84,400	632,788	Apr 22 04:18 PM
Sirgo Mark A	Director	Apr 15	Sale	4.13	50,000	206,500	1,464,595	Apr 17 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience